Learn more about a benzodiazepine approved by the FDA in July 2020 that is now available. Acacia Pharma invites you to an educational program to discuss the intentional design, pharmacology, efficacy, and safety of a benzodiazepine for procedural sedation. Your questions about this benzodiazepine for use in procedures lasting 30 minutes or less will be answered by Dr. Randall D Ostroff, Ambulatory Anesthesiologist and Pharmaceutical Consultant practicing in Chicago, IL.

Learning Objectives:

1. Explore the current procedural sedation landscape
2. Discuss the design of ester-based, soft drugs and how they are metabolized in the body
3. Gain knowledge of the clinical characteristics of an FDA-approved sedative and hear recommendations on how to safely administer this product in all patient types

Register Here: https://samba.memberclicks.net/0521-acacia